health

Research brief: Adding a protein called viral polymerase to vaccines could potentially create a more robust, enduring immune response, scientists say.

A UCLA study raises the possibility that vaccine boosters may be equally effective in improving antibodies’ ability to target multiple variants of the virus.

Forty years ago, when a UCLA physician published a three-page report first identifying the disease that would become known as AIDS, few imagined the devastating toll that would follow.

UCLA’s Brad Sears has observed how the current pandemic has been shaped by what we did and did not learn in the past 40 years.

Though medical treatment has progressed, laws that discriminate against people based their HIV-positive status remain on the books across the United States.

UCLA Health pathologist Shangxin Yang shares what scientists know thus far and what the public needs to know to try to prevent infection.

A UCLA report identifies physical and mental health burdens among the millions who care for friends and family members.

Research brief: A UCLA-led study identifies a potential target for therapies to prevent or treat heart failure.

The veteran firefighter, who expects to earn his Ph.D. in chemistry in winter quarter, is using his knowledge to improve the health and safety of his colleagues.

A UCLA study of 12,000 health care workers found infected individuals who were unvaccinated shed more viral particles.

Using stem cell engineering and organoid technology, UCLA researchers were able to produce large quantities of powerful cancer-fighting iNKT cells.

The list is compiled based on research citations from 2010 to 2020.

UCLA researchers use super-resolution microscopy to reveal surprising new details about X inactivation in female mouse embryos.

In June, Irvin Poff became one of the oldest Americans to receive the life-changing technology.

The research suggests that interventions for people in their early 20s could be key to better outcomes later in life.

A new study “has implications for the public health system, health care providers and under-resourced communities,” said UCLA’s Arleen Brown.

The UCLA geriatric psychiatrist escaped the Nazis as a child and became a leading Alzheimer’s researcher. She died in her sleep on Oct. 1.

The study could help explain why people with damage to the hippocampus struggle with both spatial and memory tasks.

Dr. Helena Hansen, Dr. Keith Norris and Dr. Peter Tontonoz were honored.

A new study is the first to show that such an initiative could be adapted or even expanded during the pandemic.

Researchers report that all nine patients who were successfully treated for ADA-SCID in a UCLA clinical trial from 2009 to 2012 are still disease-free.

Ninety percent of parents who had a visit with Robin indicated they were “extremely likely” to request another visit.

The findings could help scientists pinpoint targets for treating Parkinson’s and Huntington’s diseases.

“We need to figure out how this is happening in order to develop treatments to stop it,” said UCLA’s Arjun Deb.

The study, co-led by UCLA scientists, evaluated nearly 5,000 people at 33 academic medical centers.